We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Withholds Support for Drugs Aimed at Duchenne Muscular Dystrophy, ALS
CHMP Withholds Support for Drugs Aimed at Duchenne Muscular Dystrophy, ALS
The EU’s Committee for Medicinal Products for Human Use (CHMP) isn’t supporting two drugs intended to treat patients with amyotrophic lateral sclerosis (ALS) and Duchenne muscular — diseases that have also struggled to get approved treatments in the US.